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High non-speciﬁc uptake of [11C]Pittsburgh compound B ([11C]PiB) in white matter and signal spillover
from white matter, due to partial volume effects, confound radioactivity measured in positron emission
tomography (PET) with [11C]PiB. We aimed to reveal the partial volume effect in absolute values of ki-
netic parameters for [11C]PiB, in terms of spillover from white matter. Dynamic data acquired in [11C]PiB
PET scans with ﬁve healthy volunteers and eight patients with Alzheimer's disease were corrected with
region-based and voxel-based partial volume corrections. Binding potential (BPND) was estimated using
the two-tissue compartment model analysis with a plasma input function. Partial volume corrections
signiﬁcantly decreased cortical BPND values. The degree of decrease in healthy volunteers (52.775.8%)
was larger than that in Alzheimer's disease patients (11.974.2%). The simulation demonstrated that
white matter spillover signals due to the partial volume effect resulted in an overestimation of cortical
BPND, with a greater degree of overestimation for lower BPND values. Thus, an overestimation due to
partial volume effects is more severe in healthy volunteers than in Alzheimer's disease patients. Partial
volume corrections may be useful for accurately quantifying Aβ deposition in cortical regions.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Alzheimer's disease (AD) is the most common form of neuro-
degenerative dementia, characterized by deposition of amyloid
beta (Aβ) protein (Braak and Braak, 1991). This pathological char-
acteristic of AD allows for in vivo imaging of Aβ deposition, which
could serve as a biomarker for AD diagnosis and the evaluation of
drug therapy. [11C]Pittsburgh compound B ([11C]PiB) was devel-
oped as a ﬁrst generation radiotracer to measure Aβ plaque de-
position in cortical gray matter regions with positron emission
tomography (PET) (Klunk et al., 2004; Mathis et al., 2003), and has
been widely used in clinical AD research (Buckner et al., 2005;
Engler et al., 2006; Rowe et al., 2007; Kerbler et al., 2015; Klupp
et al., 2015; Murray et al., 2014; Price et al., 2005).
Kinetic analysis with a compartment model has been per-
formed to estimate blood ﬂow and speciﬁc binding to receptors,
enzymes, or other proteins in tissues (Watabe et al., 2006).Inc. This is an open access article
tsubara).Compartment model analysis requires arterial blood sampling to
acquire a plasma time-activity curve (TAC) as an input function.
Some simpliﬁed methods have been developed, which do not in-
volve blood sampling, to estimate relative parameters to reference
tissue (Ichise et al., 2003; Lammertsma and Hume, 1996; Logan
et al., 1996). For [11C]PiB PET, two tissue compartment models with
four parameters (2TC) have been shown to be optimal for kinetic
analysis with arterial input function (Price et al., 2005). For the
purpose of computational simplicity and good reproducibility of
estimates in [11C]PiB studies (Lopresti et al., 2005; Tolboom et al.,
2009), a ratio of distribution volume (DVR), which is estimated by
simpliﬁed non-blood sampling methods, and standardized uptake
value (SUVR) have been widely used (Apostolova et al., 2010;
Baron et al., 2014; Mori et al., 2014; Ng et al., 2007; Potter et al.,
2013). However, the reference tissue input function model can
only estimate relative parameters and is not available in cases
where speciﬁc binding exists in the reference region – for example,
amyloid deposition in the cerebellum of patients with severe AD
(Braak et al., 1989). Compartment model analysis with arterial
input function remains a unique method for estimating absolute
parameters and is also regarded as a gold standard for estimatingunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Low spatial resolution of PET, typically between 5 and 7 mm
full-width at half maximum (FWHM), results in spill-out radio-
activity from the region of interest and spill-in from marginal re-
gions. The phenomenon is generally referred to as the ‘partial
volume effect’ (Hoffman et al., 1979). Morphological changes in
neurodegenerating brain tissue increase the partial volume effect.
For example, gyri thinned by progressive atrophy in AD results in
stronger spill-out from the gray matter regions, thereby under-
estimating cortical radioactivity, as well as overestimating the
cortical radioactivity due to spillover from white matter. Ad-
ditionally, [11C]PiB is highly distributed to the white matter, even
though amyloid does not deposit in the white matter (Klunk et al.,
2004). The high uptake in white matter makes more severe the
spillover from the white matter into the gray matter, thereby
confounding [11C]PiB radioactivity in the gray matter regions.
Some techniques to correct partial volume effect have been de-
veloped (Alessio and Kinahan, 2006; Baete et al., 2004; Meltzer
et al., 1990; Muller-Gartner et al., 1992; Rizzo et al., 2007; Rousset
et al., 1998a, 1998b; Shidahara et al., 2009; Thomas et al., 2011).
Partial volume correction (PVC) can improve the statistical power
in group comparisons (Rullmann et al., 2015; Thomas et al., 2011)
and longitudinal studies (Su et al., 2015). However, to the best of
our knowledge, the effects of partial volume effect on absolute
kinetic parameters, estimated by compartment model analysis,
have not been investigated for [11C]PiB PET and are still required to
validate the impact of partial volume effect on quantiﬁcation of
amyloid deposit in [11C]PiB PET studies.
The aim of the current study is to analyze the partial volume
effect in absolute kinetic parameters for [11C]PiB. In particular, we
focused on the effect of spillover from white matter regions on
kinetic parameters. To validate these effects, we applied region-
and voxel-based PVC to dynamic [11C]PiB PET data acquired from
healthy volunteers and AD patients, and then performed
compartment model analysis with arterial input function. Good-
ness-of-ﬁt with and without PVC was compared between three
conventional models to determine whether partial volume effect
alters the optimal model for [11C]PiB PET. Then, kinetic parameters
estimated by a two-tissue-four-parameters compartment model
(2TC) were compared between conditions with and without PVC.
We also simulated TACs with spillover from white matter to in-
terpret the observed changes in kinetic parameters with PVC.2. Materials and methods
2.1. Subjects
AD patients were recruited from Chiba University Hospital and
afﬁliated hospitals between October 2007 and January 2010. All
AD patients were diagnosed according to the National Institute of
Neurological and Communicative Diseases and Stroke/Alzheimer's
Disease and Related Disorders Association (NINCDS-ADRDA) cri-
teria (McKhann et al., 1984). Cognitive healthy control volunteers
(HVs) were recruited from the volunteer association of the Na-
tional Institute of Radiological Sciences (NIRS). A board-certiﬁed
neurologist conﬁrmed that all HVs were not cognitively impaired
and were not being treated with medications that affect the cen-
tral nervous system. All subjects were classiﬁed using the Clinical
Dementia Rating (CDR) scale (Morris, 1993): HVs corresponded to
0 and AD patients to 1 or 2. The Mini-Mental State Examination
(MMSE) (Folstein et al., 1975) was performed on all subjects to
evaluate cognitive functions. Magnetic resonance (MR) imaging
showed no notable brain tissue lesions in any healthy volunteers.
All subjects did not have any comorbidities including severe cer-
ebrovascular and neurodegenerative diseases other than dementiaand AD. An expert for neuroradiology visually evaluated PiB-po-
sitive or negative with [11C]PiB PET image to conﬁrm no HV with
PiB-positive and AD with PiB-negative were included each subject
group. We also conﬁrmed BPND, estimated as described later, in
whole cerebral cortex for all AD patients were larger than mean þ
2.5 SD of BPND for the HV group.
The study was approved by the Ethics and Radiation Safety
Committees of the National Institute of Radiological Sciences,
Chiba, Japan (approved on June 28, 2005 and April 30, 2008; ap-
proval numbers were not assigned), and were performed in ac-
cordance with the Ethical Guidelines for Medical and Health Re-
search Involving Human Subjects, issued by Ministry of Health,
Labor and Welfare, Japan Government, as well as the Declaration
of Helsinki. Written informed consent was obtained from all
subjects or their close family members.
2.2. PET procedures
All PET scans were performed with an ECAT EXACT HRþ sys-
tem (CTI-Siemens, Knoxville, TN, USA), which provides 63 sections
with a 15.5-cm axial ﬁeld-of-view. The intrinsic spatial resolution
was 4.3 mm in-plane and 4.2 mm full-width at half-maximum
(FWHM) axially (Brix et al., 1997). Data were acquired in the three-
dimensional mode with scatter correction. The acquired count
data were reconstructed by ﬁltered-back projection with a
Hanning ﬁlter (cut-off frequency: 0.4 cycles/pixel). Final in-plane
resolution was 7.5 mm FWHM. A head ﬁxation device with
thermoplastic attachments for individual ﬁt minimized head
movement during PET scans.
[11C]PiB was produced according to previously described
methods (Mathis et al., 2003). After intravenous bolus injection of
[11C]PiB (377.6732.5 MBq; 145.3762.0 GBq/μmol), dynamic
scans were performed for 90 min, consisting of three 20-s, three
40-s, one 60-s, two 3-min, ﬁve 6-min, and ﬁve 10-min frames.
A transmission scan for 10 min was ﬁrst performed for attenuation
correction. A total of 27 arterial blood samples were taken at 0, 10,
20, 30, 40, 50, 60, 70, 80, 90, and 120 s, as well as at 4, 6, 8, 10, 12,
14, 16, 18, 20, 30, 40, 50, 60, 70, 80, and 85 min after [11C]PiB in-
jection, to obtain arterial input function. The radioactivity fraction
of parent compound in plasma was determined by high-perfor-
mance liquid chromatography (HPLC). Seven blood samples from
70 s, and 4, 8, 20, 40, 60, and 70 min were measured with HPLC.
The input function for parent compound was calculated by plasma
activity and fraction interpolated by bi-exponential function.
2.3. MR imaging procedures
To acquire anatomical information for partial volume correc-
tion and other image processing, MR imaging scans were per-
formed using a 1.5 T MR scanner (Philips Medical Systems, Best,
the Netherlands). Three-dimensional volumetric acquisition of a
T1-weighted gradient echo sequence produced a gapless series of
thin transverse sections (echo time: 9.2 ms; repetition time:
21 ms; ﬂip angle: 30°; ﬁeld of view: 256 mm; acquisition matrix:
256256; slice thickness: 1 mm).
2.4. Image processing and deﬁnition for volume of interest (VOI)
PET frames were resliced to an image averaged from frames
during the ﬁrst 10 min to correct for subject head motion during
PET scans. All PET images were coregistered to space on MR
images for each subject. Space transformations from Montreal
Neurological Institute (MNI)/International Consortium for Brain
Mapping (ICBM) 152 T1 templates for each subject space were
estimated by non-linear image registration using a discrete cosine
transformation (DCT) basis function (Ashburner and Friston, 1999).
Fig. 1. MR T1 anatomical images, VOIs and SUV maps with and without PVC [GTM
and mMG] for A) a representative HV and B) a representative patient with AD.
Different colors on VOI maps mean different VOIs. Note that SUV values in each
region on GTM maps were uniform because the GTM maps were generated
with regional SUV values corrected by region-based PVC, i.e. GTM. (For inter-
pretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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tistical Parametric Mapping 8 (SPM8) package (http://www.ﬁl.ion.
ucl.ac.uk/spm/software/spm8/).
Each voxel on MR images of the subject's head was classiﬁed
into gray matter, white matter, cerebrospinal ﬂuid (CSF), bone, or
soft tissue using the “NewSegment” toolbox in SPM8, which is based
on a uniﬁed segmentation algorithm (Ashburner and Friston, 2005).
NewSegment outputs “probability” maps for each class. To acquire
the exact mask for each class, we assigned the largest probability on
the voxel for each class. For example, if probabilities for gray matter,
white matter, CSF, bone, and soft tissue on one voxel are 0.65, 0.20,
0.05, 0.10, and 0.00, respectively, this voxel would be assigned as
gray matter.
Cortical and subcortical VOIs were drawn on each subject's space
using an inverse transformation from automated anatomic labeling
(AAL) template on MNI/ICBM standard space (Tzourio-Mazoyer
et al., 2002). The VOIs were masked with a mask for gray matter
extracted from the segmentation process as described above, to
extract gray matter VOIs precisely. The masks for white matter, CSF,
bone, and soft tissue were regarded as VOIs. The VOIs for re-
presentative subjects are shown in Fig. 1. All extracted VOIs were
used in the region-based PVC described below. Seven cortical
(frontal cortex, parietal cortex, occipital cortex, lateral temporal
cortex, medial temporal cortex, anterior cingulate, and posterior
cingulate), hippocampal (hippocampusþparahippocampal gyrus),
cerebellar, and white matter VOIs were investigated in the current
study due to the strong interest in amyloid deposition for cortical
regions and missegmentation in subcortical VOIs. VOI merged with
the seven cortical VOIs was also investigated as ‘whole cerebral
cortex’.
2.5. Partial volume correction (PVC)
We applied region-based PVC, referred to as the geometric
transfer matrix (GTM) method (Rousset et al., 1998a), to determine
the inﬂuence of partial volume effect on regional kinetic para-
meters. The GTM method assumes that radioactivity is homo-
genous over a region and is affected by spillover represented with
GTM. The GTM contains the fractional radioactivity contribution
from other VOIs into interested VOI, is calculated using the re-
gional spread function (RSF), and is integrated by the point-spread
function (PSF) over each VOI. The GTM method principles and
details have been previously described (Rousset et al., 1998a). We
calculated true radioactivities on VOIs drawn as described in the
Section 2.4. A 7.5-mm FWHM Gaussian kernel was utilized as the
PSF to calculate RSF in the current study, based on actual mea-
surement of PSF with the PET scanner and preliminary validation
for uniform PSF (see Supplementary materials).
The GTM method can recover true activities for multiple re-
gions. However, it cannot recover voxel-wise computation. To
generate images corrected for partial volume effect, we also ap-
plied voxel-based PVC, referred to as the modiﬁed Müller-Gärtner
method (mMG) (Muller-Gartner et al., 1992; Rousset et al., 1998b).
Brieﬂy, true radioactivity in gray matter was estimated by sub-
traction with true radioactivity in white matter and other extra
regions estimated with GTM and smoothed with PSF, and dividing
with regional spread function of gray matter itself.
Standardized uptake value (SUV) maps for PET images with and
without PVC were calculated using the injected dose per body
weight. To demonstrate maps for speciﬁc binding, SUV at the late
phase (SUV60), which was 50–70 min after injection, was
integrated.
2.6. Kinetic modeling for [11C]PiB PET with PVC
To determine whether PVC can alter the optimal [11C]PiBmodel, we compared goodness-of-ﬁt for compartment model
analysis between three models: i) two-tissue-four-parameters
compartment model (2TC); ii) two-tissue-three-parameters com-
partment model (2TC3k), which assumes k4¼0 in 2TC; and iii)
one-tissue compartment model (1TC). We determined the optimal
model with the lowest Akaike information criteria (AIC) (Akaike,
1973). The arterial input function for unmetabolized [11C]PiB was
acquired as described in section “PET procedures” and was used in
all compartment model analysis. Blood component was con-
sidered in the all compartment model analysis, and blood volume
(Vb) was estimated as well as rate constants (K1, k2, k3 and k4). All
kinetic analyses were performed with PyBLD, which is a Python-
based version of the BLD system (Carson et al., 1981) (http://www.
rim.cyric.tohoku.ac.jp/software/pybld/pybld.html).2.7. Estimation of kinetic parameters for [11C]PiB PET with PVC
For subjects and regions ﬁtted with 2TC best, binding potential
relative to the nondisplaceable radiotracer concentration in the
brain (BPND), and total distribution volume (VT) were calculated as
follows:
( ) ( )= ⋅ + ( )V K k k k/ 1 / 1T 1 2 3 4
Table 1
Subject proﬁles.
Healthy volunteers (HVs) AD patients
N 5 8
Age (years) 60–77 (72.076.9) 56–79 (68.0710.7)
Sex (female/male) 3/2 4/4
Body weight [kg] 41.9–70.2 (56.5713.1) 36.3–77.0 (51.3713.8)
Injected dose [MBq] 358.5–421.8 322.3–417.4
(392.7729.9) (368.2735.2)
Speciﬁc activity [GBq/
μmol]
118.2–306.9 49.1–151.8
(185.6777.5) (120.2735.7)
CDR 0 1–2
MMSE 25–30 (28.272.2) 13–26 (18.874.4)
AD: Alzheimer's disease; CDR: Clinical Dementia Rating; MMSE: Mini-Mental State
Examination.
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Furthermore, to quantify the effect of PVC on kinetic para-
meters ((parameter with PVC)/(parameter without PVC)) was
calculated as the “PVC factor.” The % change for all estimates
[((parameter with PVC)(parameter without PVC))/(parameter
without PVC)100] was also calculated to quantify changes with
PVC. Differences between estimates with and without PVC were
tested with the paired t-test.
For reference, we estimated and compared ratio of distribution
volume (DVR) by Logan analysis with reference tissue input func-
tion (Logan et al., 1996). The details are described in Supplemen-
tary materials.
2.8. Simulation for spillover from white matter
We simulated TACs to reveal how spillover from white matter
affects values for speciﬁc binding of [11C]PiB and changes with
amyloid deposition. First, we calculated the TAC in gray matter and
white matter for healthy controls using the two-tissue-four-para-
meters compartment model. K1, k2, k3, and k4 values reported from
a previous study (Price et al., 2005) [K1¼0.2500 mL/mL/min;
k2¼0.1520 min1; k3¼0.0152 min1; k4¼0.0108 min1] were
used as healthy gray matter values. To validate the effect of spil-
lover from white matter purely, the white matter TAC was calcu-
lated with ﬁxing K1/k2 and k4 between gray and white matters. K1
in white matter (K1wm) was assumed as K1wm¼(1/4)K1 (Meyer
et al., 1978). k3 in white matter (k3wm) was roughly determined as
1.5 times of k3 in gray matter based on SUV values reported in the
previous study (Price et al., 2005). The blood volume was set to
zero. The arterial input function averaged during HVs as below
was used to calculate the TACs.
Second, to simulate changes in speciﬁc binding, we altered k3 in
the range of 0–0.0760 min1, which corresponded to 0–5 times as
many values in gray matter for HV, and then calculated TACs. The
change in k3 mimics progress in amyloid deposition with AD. Next,
TACs with the spillover from white matter were calculated from
gray matter and white matter TACs simulated as above, using the
following equation:
= · + · ( )C p C p C 3PET gm gm wm wm
where CPET was total radioactivity concentration, Cgm and Cwm
were radioactivity concentrations in gray matter and white matter,
respectively, and pgm and pwm were the proportions of gray matter
and white matter in total radioactivity, respectively. pgm and pwm
were ﬁxed to 0.75 and 0.25, respectively, based on the regional
spread function in gray matter calculated as described below (data
not shown).
Finally, we estimated K1, k2, k3, and k4 for simulated TACs with
and without the spillover from white matter using the two-tissue
compartment model analysis, and then calculated the binding
potential (BPND¼k3/k4). The %bias for estimates to value without
the spillover ((x xtrue)/xtrue100) was also calculated.3. Results
3.1. Subjects
All AD patients and no HVs were classiﬁed as PiB-positive (Aβ-
positive) according to visual assessment of SUV images. Eight AD
patients and ﬁve age-matched HVs were included in further ana-
lyses. Demographic and clinical proﬁles of participants are sum-
marized in Table 1. There was no signiﬁcant difference in age and
gender between the HV and AD groups (p¼0.428 [Welch's t-test]
and p¼1.000 [Fisher's exact test], respectively). Signiﬁcantdifferences were observed in MMSE and CDR between HV and AD
groups (po0.001 [Welch's t-test and Mann-Whitney U test,
respectively]).
3.2. Images and TACs corrected for the partial volume effect
A higher contrast between gray matter and white matter was
observed in images with PVC than ones without PVC, as shown in
Fig. 1. TACs drawn on the top of Fig. 2 depict higher tracer uptake
and faster clearance in the whole cerebral cortex with PVC than
ones without PVC. Similar trends were also observed in TACs for
each cortical region. Trends for white matter TACs were opposite
to those for cortical gray matter regions, and lower uptake and
slower clearance than TACs without PVC was also observed.
3.3. Modeling for dynamic [11C]PiB PET data with PVC
The numbers of regions best ﬁtted with 2TC, 2TC3k, or 1TC are
shown in Fig. 3. 2TC was ﬁtted most appropriately for most of the
regions, even with PVC. Optimal model conversions from 2TC to
2TC3k with PVC were observed in eight regions of three HVs and
two AD patients, including one occipital cortex, four medial tem-
poral cortex regions, and three cerebellum regions. From the 2TC
analysis of these cases, the k3 and k4 estimations were
instable [CoV (¼standard error/estimated value)4100%]. In the
cerebellum of one AD patient, 2TC3k was optimal both with and
without PVC. There was no observed case that ﬁtted best with 1TC.
We mention later only results for cases that ﬁt best with 2TC.
3.4. Changes in kinetic parameters with PVC
The BPND in cortical regions for both HVs and AD patients de-
creased signiﬁcantly by PVC with GTM [po0.05], as shown in
Table 2, S1, and S2. The BPND in white matter regions increased
signiﬁcantly by PVC, which was in contrast to cortical gray matter
regions. The differences in cortical BPND with and without PVC in
HVs were higher than in AD patients, as shown in Fig. 4.
The relationship between BPND with PVC and the PVC factor for
BPND in cortical VOIs is shown in Fig. 5. In AD patients with
moderate and high BPND (41) with PVC, the PVC factors were
approximately identical. In HVs with low BPND with PVC (o1),
PVC factors o1 were observed, indicating larger partial volume
effect to BPND than in the AD patients.
K1 was signiﬁcantly increased by PVC in all gray matter regions
for both HVs and AD patients, as shown in Table 2, S1, and S2. The
K1 increase in gray matter corresponded to decreases of K1 in
white matter regions. VT was also signiﬁcantly increased in cortical
gray matter regions by PVC, but not in the hippocampus and
cerebellum. SUV60 in HVs was signiﬁcantly decreased, whereas it
Fig. 2. TACs without (circle and solid line) and with PVC (GTM; triangle and dashed line) in the representative regions (whole cerebral cortex (top) and white matter
(bottom)), averaged during HVs (left column) and patients with AD (right column). The radioactivity is indicated by standardized uptake value (SUV).
Fig. 3. The total numbers of regions best ﬁtted with 2TC, 2TC3k, or 1TC.
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observed in some cortical regions. The estimated parameters in
cortical regions corrected with mMG were nearly identical to
those with GTM (o5% differences from GTM), except for those in
the medial temporal cortex.3.5. Simulation of spillover from white matter
TACs simulated for spillover from white matter are shown in
Figure S1. A larger bias of BPND estimated from TACs with spillover
was observed in lower true k3. The bias trends correspond to re-
sults observed in HVs and AD patients in the current study (see
also Fig. 5).4. Discussion
4.1. Spillover from white matter
Signiﬁcantly decreased kinetic parameters for BPND by PVC at
the cortical gray matter regions demonstrate the overestimation of
kinetic parameters by partial volume effect. The simulation results
demonstrated that the overestimation of cortical BPND was due to
spillover of signals between gray and white matter regions.
Especially, the amounts of overestimation were large, in particular
in cases with much lower BPND in gray matter than in white
matter, such as HVs. These results reﬂect the effect of spillover
from white matter is predominant in the low BPND cases. A uni-
form PVC factor of BPND was observed in cases with moderate and
high BPND ratios, which corresponded with most AD patient cases.
The PVC factors corresponded to difference in BPND between gray
matter and white matter regions. These ﬁndings indicate that
spillover fromwhite matter can induce a considerable bias in BPND
in cases where white matter accumulation is high relative to gray
matter.
Previous studies have demonstrated higher uptake in white
matter than in cortical regions, and white matter uptake affects
visual assessment in [11C]PiB PET (Hosokawa et al., 2015, 2014).
Another recent study comparing pre-mortem [11C]PiB PET and
post-mortem amyloid deposition showed that accumulation at
white matter and its spillover can result in an increased number of
false positives during early detection of amyloid deposition
(Villeneuve et al., 2015). These previous ﬁndings imply that spil-
lover from white matter could be problematic during early de-
tection of amyloid deposition. Findings from the present study
indicated that PVC could remove the spillover effect from white
matter, even with considerable uptake on white matter relative to
gray matter, such as in early AD. Therefore, PVC could help with
detection of subtle amyloid deposition in early AD patients.
Table 2
Estimated parameters, their % changes, and p-values compared between with and without partial volume correction with geometric transfer matrix (GTM) method for
healthy volunteers and patients with AD.
Healthy volunteers (n¼5) K1 (g/mL/min) BPND VT (g/mL) SUV60
Regions
Whole cerebral Without PVC 0.214 (13.1) 0.86 (27.3) 2.21 (20.1) 0.575 (23.2)
cortex With PVC 0.320 (11.3) 0.42 (41.3) 2.36 (18.5) 0.514 (23.6)
% Change 49.973.8 52.775.8 7.272.5 5.475.9
p o0.001 o0.001 o0.001 0.001
Cerebellum Without PVC 0.222 (17.1) 0.46 (9.9) 1.91 (14.6) 0.516 (20.1)
With PVC 0.302 (22.1) 0.26 (12.2) 1.96 (14.5) 0.429 (26.4)
% Change 35.276.5 43.3711.4 2.474.3 8.8710.2
p 0.012 0.012 0.323 0.006
White matter Without PVC 0.177 (13.7) 1.65 (14.9) 2.88 (24.7) 0.770 (28.3)
With PVC 0.134 (17.0) 2.49 (21.3) 3.37 (27.7) 0.950 (31.1)
% Change 24.674.0 49.679.2 16.176.1 11.2712.2
p o0.001 0.003 0.010 0.007
AD patients (n¼8) K1 (g/mL/min) BPND VT (g/mL) SUV60
Regions
Whole cerebral Without PVC 0.161 (34.2) 2.93 (49.2) 3.47 (33.3) 0.873 (25.9)
cortex With PVC 0.238 (33.3) 2.58 (47.8) 4.61 (32.5) 1.123 (30.4)
% Change 47.873.8 11.974.2 33.373.5 13.7715.8
p o0.001 0.004 o0.001 o0.001
Cerebellum Without PVC 0.186 (33.4) 1.41 (41.1) 2.07 (18.0) 0.549 (20.8)
With PVC 0.249 (33.4) 0.85 (53.5) 1.97 (23.8) 0.474 (31.5)
% Change 33.472.7 41.9713.2 5.379.1 7.7710.8
p o0.001 0.002 0.292 0.010
White matter Without PVC 0.142 (32.8) 3.24 (52.5) 3.31 (30.9) 0.862 (21.7)
With PVC 0.116 (32.8) 3.95 (62.0) 3.33 (30.6) 0.884 (19.2)
% Change 18.473.3 19.178.6 1.075.4 1.775.6
p o0.001 0.034 0.754 0.338
AD: Alzheimer's disease; PVC: Partial volume correction.
Values on rows “Without PVC” and “With PVC” indicate mean (%CoV). %CoV¼SD/mean100%.
Values on the row “% Change” indicate mean7SD.
%Change¼(values with PVCvalues without PVC)/values without PVC100%.
Fig. 5. Scatter plot of PVC factor for BPND in cortical VOIs. Gray line indicates si-
mulated proﬁles for ratio between true BPND and those estimated from TACs with
white matter spillover, with the PVC factor in the simulation. Dashed line indicates
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trolled and equivocal population are required to reveal the use-
fulness of PVC to detect subtle amyloid and diagnose early AD.
Our ﬁndings show that [11C]PiB PET could extend to studies
with other radiotracers, which are highly distributed to the white
matter region, for amyloid. In general, 18F-labeled ligands are re-
garded to have higher non-speciﬁc binding in the white matter
than 11C-labeled ligands due to greater lipophilicity (Kepe et al.,
2013). For example, [18F]ﬂutemetamol has been reported to dis-
tribute to the white matter region more than [11C]PiB (Mountz
et al., 2015; Rowe et al., 2010). Thus, more severe overestimation of
BPND by white matter spillover could be observed in amyloid PET
studies with 18F-labeled ligands. However, further PET studies
with the other radiotracers that have a low distribution to the
white matter, such as [11C]AZD2184 (Nyberg et al., 2009), are
needed.Fig. 4. Boxplot (left) and line plots (center: HV; right: AD) of BPND in whole cerebral cortex without and with PVC (GTM).
identical PVC factor.
K. Matsubara et al. / NeuroImage 143 (2016) 316–3243224.2. Partial volume effect on kinetic analysis in [11C]PiB PET
The compartment model analysis with arterial input function
allows us to expect the partial volume effect inﬂuence on kinetic
parameters estimated from the reference tissue input function
method. For example, signiﬁcantly increased cortical VT with PVC
was observed, although there was no signiﬁcant change in cere-
bellar VT, which suggests that PVC could elevate apparent values of
DVR and BPND [DVR 1] calculated with reference tissue input
function. Indeed, a previous study showed elevated BPND by PVC in
[11C]PiB PET, which was estimated using the Logan analysis with
reference tissue input function (Su et al., 2015). Findings from the
compartment model analysis in the present study could provide a
better understanding of the partial volume effect in kinetic ana-
lysis using the reference tissue input function method in previous
amyloid PET studies (Su et al., 2015; Thomas et al., 2011).
The increase in K1 and VT values with PVC reﬂects an under-
estimation of [11C]PiB uptake due to spillover from gray matter
regions by partial volume effect. These results imply that PVC can
correct the signal underestimation due to atrophy with partial
volume effect, as well as the overestimation of speciﬁc binding by
white matter spillover. These ﬁndings demonstrate the usefulness
of PVC for accurately estimating kinetic parameters in [11C]PiB PET.
2TC was an optimal ﬁt in most cases, irrespective of PVC. Re-
sults suggest that partial volume effect and its correction do not
affect the kinetic model choice for [11C]PiB. In several regions of
some subjects, 2TC3k was the optimal ﬁt, corresponding to results
from a previous study showing that ﬁttings with 2TC were not
achieved in several regions for some subjects (Price et al., 2005).
These results showed the existence of a subtype with [11C]PiB
kinetic indicating k4¼0. However, the computational instability in
the k4 estimation with 2TC can also explain the optimal ﬁt with
2TC3k in some cases.
Vb without and with PVC were also estimated with the com-
partment model including blood component in the current study.
However, interpretation of the estimated Vb should be carefully
considered for the following reasons. In theory, degrees of partial
volume effect could be different between the tissue and blood
components; these regions have different object sizes. To the best
of our knowledge, there is no PVC method which can handle the
tissue and blood components separately. The sum of both the
components are usually applied as PVC factors in the existing MR-
based PVC methods. The present results, the signiﬁcantly larger Vb
in some regions with PVC, can be simply due to the increase in
apparent tissue uptake of [11C]PiB at early phase by PVC. The Vb
estimates with PVC are not true estimates free from partial volume
effect, and rather, should be considered as merely a parameter to
ﬁt curves. Interpretation of blood volume with PVC still remains an
open question.
PVC can amplify instability of the compartment model analysis
due to propagation of noise in the PET signal. Indeed, the error in
k4 estimation with 2TC was larger with PVC than without PVC in
some cases. A previous study recommended the use of a reference
tissue input function method for studies requiring statistical sta-
bility, such as discriminatory and longitudinal studies (Lopresti
et al., 2005). We suggest that the reference tissue input function
method with PVC is a better choice for discriminatory and long-
itudinal studies. However, it is important to note that the present
study focused on validating the partial volume effect in kinetic
parameters, which was the reason for selecting the compartment
model analysis with arterial input function.
GTM method assumes tracer uptake homogenous in each re-
gion. The assumption can be violated in cases with in-
homogeneous lesion such as local amyloid deposition and white
matter pathology. The violation could affect kinetic parameters in
each voxel and thus visual inspection of amyloid deposition withparametric map. In the current study, the similar values in kinetic
parameters averaged in each VOI between GTM and mMG meth-
ods were observed because the averaging in VOI canceled the ef-
fect in the violation of homogeneity. Further studies to investigate
the effect of PVC in voxelwise analysis are required. mMG could
not be the best PVC method for voxelwise analysis in amyloid PET
studies because the method assumes homogeneous radioactivity
per tissue fractional volume in whole gray matter; amounts of
spillover in the GM regions are calculated only from the MR seg-
mented tissue fractions (Muller-Gartner et al., 1992; Rousset et al.,
1998b). This assumption causes erroneous PVC results, especially
in voxels surrounded by high uptake regions, as pointed out in the
previous report (Thomas et al., 2011). We should consider differ-
ences in characteristic of methods in choice of PVC methods. Some
other voxel-based PVC methods (Bousse et al., 2012; Thomas et al.,
2011) can be candidates in voxelwise analysis and visual inspec-
tion with parametric maps.
Another limitation in the present study is misalignment be-
tween transmission and emission scans due to subjects’ head
motion during the scan, which can be problematic especially in
scans with AD patients. The misalignment between transmission
and emission scans were not considered in the present study,
whereas the motion correction during emission frames was per-
formed. The previous amyloid PET study has indicated head mo-
tion increases variability of DVR (Wardak et al., 2010). Thus, the
misalignment between transmission and emission can affect sta-
tistical power of kinetic parameters in amyloid PET study. Further
studies are required to reveal the effect of the misalignment in
partial volume effect on amyloid PET.5. Conclusions
The results from the present study revealed an overestimation
of speciﬁc binding for [11C]PiB by white matter spillover associated
with partial volume effect. This remarkable overestimation was
observed in cases with considerable white matter uptake relatively
to gray matter uptake such as HVs, rather than AD patients. The
underestimation of K1 and VT due to partial volume effect were
also demonstrated. The appropriate PVC can avoid the over- and
under-estimation of kinetic parameters. These ﬁndings demon-
strate that PVC can help to better understand the true kinetic for
[11C]PiB and can be useful for accurately estimating amyloid
deposition in [11C]PiB PET.Disclosure
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